{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:01:50Z","timestamp":1781420510760,"version":"3.54.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n            <jats:title>Aims<\/jats:title>\n            <jats:p>French clinical practice guidelines on the use of liver biopsy (LB) published in 2002 focused on ultrasound guidance (USG) and ambulatory LB. The aims of this study were as follows: (i) to evaluate the number and indications for LB for chronic liver diseases and (ii) to evaluate LB modalities according to French clinical practice guidelines. Data recorded included the number and indications for LB, procedures, use of USG, and complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 131 centers participated: 8741 LB were performed versus 12\u2009000 in 1997; ambulatory LB was performed in 48.6% of cases (vs. 27% in 1997; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). USG during LB was used in 89.7% of the centers, among which 42 (31.8%) used real-time USG (vs. 56 and 22%, respectively, in 1997; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01). The main indications for LB were chronic hepatitis C in 24.6% of cases (vs. 54.1% in 1997; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), and viral B or B-delta in 15.0% (vs. 5.8%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Severe complications were less frequent at centers with systematical USG during LB than at those without such guidance (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In this large nationwide study, major trends were as follows: (i) a marked decrease in LB number, related to a decrease in LB for chronic viral hepatitis C; (ii) increased use of USG; and (iii) an increase in the number of ambulatory LB. Severe complications decreased significantly at centers in which USG was systematically applied.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000000683","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T16:03:28Z","timestamp":1466784208000},"page":"e26-e32","source":"Crossref","is-referenced-by-count":13,"title":["Major changes in the number and indications of liver biopsy for chronic liver diseases over one decade in France"],"prefix":"10.1097","volume":"28","author":[{"given":"Jean-Fran\u00e7ois D.","family":"Cadranel","sequence":"first","affiliation":[{"name":"Department of Hepato-Gastroenterology, Alcohology and Nutrition, Laennec Hospital, Creil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Nousbaum","sequence":"additional","affiliation":[{"name":"Department of Hepato-Gastroenterology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maelenn","family":"Gouillou","sequence":"additional","affiliation":[{"name":"Clinical Investigation Center INSERM 1412, University Hospital La Cavale Blanche, Brest"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Hanslik","sequence":"additional","affiliation":[{"name":"Hepato-Gastroenterology Office, Montpellier"},{"name":"ANGH: French Association of Hepato-Gastroenterologists of Primary Referral Hospitals, Montfermeil"},{"name":"AFEF: French Association for the Study of the Liver"},{"name":"CREGG: French Association of Private Gastroenterology, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2014.03.006","article-title":"Improving performance of liver biopsy in fibrosis assessment","volume":"61","author":"Asselah","year":"2014","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"R4-20230916","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1478-3231.2010.02380.x","article-title":"How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?","volume":"31","author":"Castera","year":"2011","journal-title":"Liver Int"},{"key":"R5-20230916","first-page":"848","article-title":"Clinical practice guidelines on the use of liver biopsy","volume":"26","author":"Nousbaum","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"R6-20230916","first-page":"77","article-title":"Practices of transcutaneous liver biopsies in France. Results of a retrospective nationwide study","volume":"25","author":"Cadranel","year":"2001","journal-title":"Gastroenterol Clin Biol"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)","volume":"32","author":"Cadranel","year":"2000","journal-title":"Hepatology"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/gut.52.12.1784","article-title":"Treatment of hepatitis C. The 2002 French consensus","volume":"52","author":"Dhumeaux","year":"2003","journal-title":"Gut"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2006.12.013","article-title":"Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C","volume":"46","author":"Leroy","year":"2007","journal-title":"J Hepatol"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1572-0241.2006.00411.x","article-title":"Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study","volume":"101","author":"Halfon","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep.20935","article-title":"A novel panel of blood markers to assess the degree of liver fibrosis","volume":"42","author":"Cal\u00e8s","year":"2005","journal-title":"Hepatology"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2006.12.002","article-title":"Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?","volume":"46","author":"Castera","year":"2007","journal-title":"J Hepatol"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2012.03.021","article-title":"National patterns and predictors of liver biopsy use for management of hepatitis C","volume":"57","author":"Groessl","year":"2012","journal-title":"J Hepatol"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1478-3231.2008.01691.x","article-title":"Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies","volume":"28","author":"Myers","year":"2008","journal-title":"Liver Int"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"e75267","DOI":"10.1371\/journal.pone.0075267","article-title":"Molecular epidemiology and clinical characteristics of hepatitis B identified through the French mandatory notification system","volume":"8","author":"Thibault","year":"2013","journal-title":"PLoS One"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jhep.2012.11.044","article-title":"Hepatitis B screening: who to target? A French sexually transmitted infection clinic experience","volume":"58","author":"Spenatto","year":"2013","journal-title":"J Hepatol"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2036.2007.03400.x","article-title":"Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis \u2013 results of a nationwide survey","volume":"26","author":"Cadranel","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3748\/wjg.v20.i2.401","article-title":"Then and now: the progress in hepatitis B treatment over the past 20 years","volume":"20","author":"Halegoua-De Marzio","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/jgh.12213","article-title":"Long-term therapy for chronic hepatitis B: hepatitis B virus DNA suppression leading to cirrhosis reversal","volume":"28","author":"Marcellin","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-230X-14-118","article-title":"FibroSure as a noninvasive of liver fibrosis and inflammation in chronic hepatitis B","volume":"14","author":"Zeremski","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1478-3231.2008.01802.x","article-title":"Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B","volume":"29","author":"Marcellin","year":"2009","journal-title":"Liver Int"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.22007","article-title":"Acute viral hepatitis increases liver stiffness values measured by transient elastography","volume":"47","author":"Arena","year":"2008","journal-title":"Hepatology"},{"key":"R27-20230916","first-page":"539","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"33","year":"2009","journal-title":"J Hepatol"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"R29-20230916","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"R30-20230916","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O\u2019Shea","year":"2010","journal-title":"Hepatology"},{"key":"R31-20230916","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.3748\/wjg.v19.i44.7825","article-title":"Is liver biopsy necessary in the management of alcoholic hepatitis?","volume":"19","author":"Dhanda","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R32-20230916","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"R33-20230916","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"R34-20230916","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"key":"R35-20230916","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jhep.2008.08.011","article-title":"Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease","volume":"49","author":"Nahon","year":"2008","journal-title":"J Hepatol"},{"key":"R36-20230916","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"R37-20230916","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2006.05.008","article-title":"Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study","volume":"45","author":"de L\u00e9dinghen","year":"2006","journal-title":"J Hepatol"},{"key":"R38-20230916","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1478-3231.2010.02314.x","article-title":"Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease","volume":"30","author":"Cal\u00e8s","year":"2010","journal-title":"Liver Int"},{"key":"R39-20230916","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-6-34","article-title":"Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Poynard","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R40-20230916","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"R41-20230916","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.510230522","article-title":"The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy","volume":"23","author":"Lindor","year":"1996","journal-title":"Hepatology"},{"key":"R42-20230916","first-page":"1318","article-title":"Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site","volume":"91","author":"Caturelli","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R43-20230916","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0168-8278(99)80187-1","article-title":"Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs","volume":"30","author":"Farrell","year":"1999","journal-title":"J Hepatol"},{"key":"R44-20230916","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1478-3231.2007.01592.x","article-title":"Percutaneous liver biopsy in clinical practice","volume":"27","author":"Al Knawy","year":"2007","journal-title":"Liver Int"},{"issue":"Suppl S1","key":"R45-20230916","first-page":"485A","article-title":"Abdominal ultrasonography strongly reduces the risk of complications and improves success rate after liver biopsy: results of a meta-analysis comparing the use of ultrasound guidance to the \u2018blind method\u2019","volume":"62","author":"Garioud","year":"2015","journal-title":"Hepatology"},{"key":"R46-20230916","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1572-0241.2002.05788.x","article-title":"Current liver biopsy practices for suspected parenchymal liver diseases in the United States: the evolving role of radiologists","volume":"97","author":"Angtuaco","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R47-20230916","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/gut.36.3.437","article-title":"Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London","volume":"36","author":"Gilmore","year":"1995","journal-title":"Gut"},{"key":"R48-20230916","first-page":"205","article-title":"Early discharge after core liver biopsy: is it safe and cost-effective?","volume":"53","author":"Bicknell","year":"2002","journal-title":"Can Assoc Radiol J"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042737-201609000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T15:09:04Z","timestamp":1694876944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042737-201609000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000000683","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}